title: Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis.
authors.forename: M N
authors.initials: MN
authors.lastname: Upton-Rice
authors.forename: M E
authors.initials: ME
authors.lastname: Cudkowicz
authors.forename: L
authors.initials: L
authors.lastname: Warren
authors.forename: R K
authors.initials: RK
authors.lastname: Mathew
authors.forename: J M
authors.initials: JM
authors.lastname: Ren
authors.forename: S P
authors.initials: SP
authors.lastname: Finklestein
authors.forename: R H
authors.initials: RH
authors.lastname: Brown
mesh_terms: D000818:Animals; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007274:Injections, Intraperitoneal; D051379:Mice; D008822:Mice, Transgenic; D016472:Motor Neuron Disease / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D013482:Superoxide Dismutase / Q000235:genetics*
chemical_list: D016222:Fibroblast Growth Factor 2; D013482:Superoxide Dismutase